Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Conditions:   Acute Leukemia;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Adult Diffuse Large Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Burkitt Lymphoma;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Chronic Myelomonocytic Leukemia;   Hodgkin Lymphom a;   Lymphoblastic Lymphoma;   Lymphoplasmacytic Lymphoma;   Mantle Cell Lymphoma;   Mixed Phenotype Acute Leukemia;   Myelodysplastic Syndrome;   Prolymphocytic Leukemia;   Refractory Chronic Lymphocytic Leukemia;   Refractory Follicular Lymphoma;   Refractory Marginal Zone  Lymphoma;   Refractory Small Lymphocytic Lymphoma Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Cyclosporine;   Biological: Filgrastim;   Drug: Fludarabine;   Drug: Mycophenolate Mofetil;   Drug: Mycophenolate Sodium;   Radiation: Total-Body Irradiation;   Drug: Treosulfan Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials